MANTUANO, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 2.385
AS - Asia 1.063
EU - Europa 1.023
SA - Sud America 279
Continente sconosciuto - Info sul continente non disponibili 172
AF - Africa 60
OC - Oceania 8
Totale 4.990
Nazione #
US - Stati Uniti d'America 2.284
IT - Italia 501
SG - Singapore 433
BR - Brasile 219
CN - Cina 205
HK - Hong Kong 113
RU - Federazione Russa 100
VN - Vietnam 76
CA - Canada 71
SE - Svezia 68
DE - Germania 66
FR - Francia 62
FI - Finlandia 54
BD - Bangladesh 53
GB - Regno Unito 53
IN - India 40
ES - Italia 25
NL - Olanda 25
CI - Costa d'Avorio 24
ID - Indonesia 24
JP - Giappone 22
MX - Messico 21
AR - Argentina 13
IQ - Iraq 13
PL - Polonia 12
TR - Turchia 11
ZA - Sudafrica 11
CO - Colombia 10
UZ - Uzbekistan 10
AT - Austria 9
PK - Pakistan 9
EC - Ecuador 8
PE - Perù 8
AU - Australia 7
SA - Arabia Saudita 7
UA - Ucraina 7
EG - Egitto 6
MA - Marocco 6
VE - Venezuela 6
CZ - Repubblica Ceca 5
IE - Irlanda 5
BE - Belgio 4
BO - Bolivia 4
CL - Cile 4
DZ - Algeria 4
JO - Giordania 4
KE - Kenya 4
KG - Kirghizistan 4
LT - Lituania 4
MY - Malesia 4
PH - Filippine 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DK - Danimarca 3
IL - Israele 3
KR - Corea 3
PY - Paraguay 3
UY - Uruguay 3
AL - Albania 2
BY - Bielorussia 2
CH - Svizzera 2
CR - Costa Rica 2
EE - Estonia 2
GR - Grecia 2
KZ - Kazakistan 2
LB - Libano 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
GA - Gabon 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
LC - Santa Lucia 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
SV - El Salvador 1
TJ - Tagikistan 1
Totale 4.818
Città #
Ashburn 284
Singapore 253
San Jose 189
Fairfield 172
Chandler 159
Dallas 140
Hong Kong 107
Woodbridge 104
Bari 102
Milan 87
Cambridge 83
Beijing 74
Houston 71
Council Bluffs 69
Nyköping 65
Seattle 63
Wilmington 57
Los Angeles 50
New York 41
Helsinki 40
Bitetto 38
Bitonto 29
Victoria 27
Lauterbourg 26
Santa Clara 26
Rome 25
Abidjan 24
Ho Chi Minh City 23
Ann Arbor 22
Jakarta 20
Lawrence 18
Roxbury 17
São Paulo 17
Brooklyn 16
Chicago 16
Hanoi 16
Munich 16
Des Moines 15
Montreal 15
Taranto 15
Columbus 14
Falkenstein 14
Grottaglie 13
Inglewood 13
Buffalo 12
Frankfurt am Main 12
Chennai 11
Turku 11
London 10
Mexico City 10
Tokyo 10
Toronto 10
Amsterdam 9
Boardman 9
Nuremberg 9
Orem 9
Rio de Janeiro 9
Tashkent 9
Denver 8
San Diego 8
Atlanta 7
Belo Horizonte 7
Campinas 7
Nanjing 7
North Bergen 7
The Dalles 7
Trieste 7
Warsaw 7
Dong Ket 6
Groningen 6
Johannesburg 6
Naples 6
Phoenix 6
Shanghai 6
Turin 6
Brno 5
Jiaxing 5
Nakano 5
Philadelphia 5
Poplar 5
Portsmouth 5
Redwood City 5
Sennori 5
Aldeatejada 4
Ankara 4
Baghdad 4
Bauru 4
Boston 4
Brescia 4
Brussels 4
Dublin 4
Figino 4
Goiânia 4
Haiphong 4
Jeddah 4
Luton 4
Melbourne 4
Mumbai 4
Nanchang 4
Paris 4
Totale 3.047
Nome #
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future 349
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies 297
A long-term treatment with taurine prevents cardiac dysfunction in mdx mice 250
Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of Duchenne muscular dystrophy: a comparison with the gold standard, α-methyl prednisolone. 238
Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy 236
Contractile efficiency of dystrophic mdx mouse muscle: In vivo and ex vivo assessment of adaptation to exercise of functional end points 235
Dasatinib/HP-β-CD inclusion complex based aqueous formulation as a promising tool for the treatment of paediatric neuromuscular disorders 214
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy. 196
BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: preclinical evaluation in a murine model of hind limb unloading 161
Ergogenic effect of bcaas and l-alanine supplementation: Proof-of-concept study in a murine model of physiological exercise 158
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity 151
Synthetic lethality to overcome cancer drug resistance 150
Alteration of stim1/orai1-mediated soce in skeletal muscle: Impact in genetic muscle diseases and beyond 150
Ultrasonography validation for early alteration of diaphragm echodensity and function in the mdx mouse model of Duchenne muscular dystrophy 143
Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds 142
"The Social Network" and Muscular Dystrophies: The Lesson Learnt about the Niche Environment as a Target for Therapeutic Strategies 137
LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model 134
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 124
β‐Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation 124
Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients 120
Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia 118
Effect of exercise on telomere length and telomere proteins expression in mdx mice 102
Determination of qPCR reference genes suitable for normalizing gene expression in a novel model of Duchenne muscular dystrophy, the D2-mdx mouse 100
Branched-chain amino acids and L-alanine supplementation ameliorate calcium dyshomeostasis in sarcopenia: New insights for nutritional interventions 99
null 93
Synergistic antiproliferative and antiangiogenic effects of EGFR and mTOR inhibitors 93
Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase. 85
Preclinical Ultrasonography in Rodent Models of Neuromuscular Disorders: The State of the Art for Diagnostic and Therapeutic Applications 85
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future 81
On the use of D2.B10-Dmdmdx/J (D2.mdx) Versus C57BL/10ScSn-Dmdmdx/J (mdx) Mouse Models for Preclinical Studies on Duchenne Muscular Dystrophy: A Cautionary Note from Members of the TREAT-NMD Advisory Committee on Therapeutics 63
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 62
Clinical course and management challenges in Lafora disease: a narrative analysis in an Apulian cohort 55
Data on protein abundance alteration induced by chronic exercise in mdx mice model of Duchenne muscular dystrophy and potential modulation by apocynin and taurine 53
PRE-CLINICAL ASSESSMENT OF THE ROLE OF THE COMPLEMENT SYSTEM IN TRIGGERING FIBROSIS IN DUCHENNE MUSCULAR DYSTROPHY: TOWARDS NOVEL THERAPEUTIC TARGETS 42
A two-site collaborative study of electrical impedance myography for evaluation of disease progression in murine Duchenne muscular dystrophy models 29
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 26
Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model. 21
Natural history study of the D2-mdx mouse for Duchenne muscular dystrophy: a comparison across two independent study sites 14
Validation of exploratory biomarkers of sarcopenia in community-dwelling older adults: insights from the IN-TEMPO clinical trial. 13
Branched-chain amino acid supplementation in a mouse model of ageing: Effects on age-related kidney fibrosis 12
254PActivation of complement cascade may trigger inflammation and fibrosis in Duchenne muscular dystrophy: a preclinical investigation on two murine models 11
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 9
Electrical impedance myography as a tool for monitoring disease progression in mouse models of Duchenne Muscular Dystrophy: a longitudinal, multisite study 8
Diaphragm‐specific effects of L‐citrulline in mdx mice highlight its potential as adjuvant of standard therapy in Duchenne muscular dystrophy 7
Totale 4.990
Categoria #
all - tutte 18.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022151 0 0 3 1 2 15 18 0 16 16 31 49
2022/2023356 26 52 26 38 29 43 2 41 56 5 21 17
2023/2024179 8 34 8 14 15 34 2 14 4 16 10 20
2024/2025882 32 6 26 28 31 101 157 109 55 54 112 171
2025/20262.285 338 78 256 173 248 102 218 80 296 226 105 165
2026/2027302 133 109 60 0 0 0 0 0 0 0 0 0
Totale 4.990